SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • October 5th, 2006 • AnorMED Inc. • Pharmaceutical preparations • British Columbia
NOW THEREFORE this Agreement witnesses that, in consideration of the premises and the covenants and agreements herein contained, the parties hereto agree as follows:
SHAREHOLDER PROTECTION RIGHTS PLAN AGREEMENTShareholder Protection Rights Plan Agreement • February 15th, 2006 • AnorMED Inc. • Pharmaceutical preparations • British Columbia
WHEREAS the Board of Directors of the Corporation has determined that it is advisable to adopt a shareholder protection rights plan (the “Rights Plan”), inter alia, in order to:
SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • October 18th, 2006 • AnorMED Inc. • Pharmaceutical preparations • British Columbia
NOW THEREFORE this Agreement witnesses that, in consideration of the premises and the covenants and agreements herein contained, the parties hereto agree as follows:
SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • October 5th, 2006 • AnorMED Inc. • Pharmaceutical preparations • British Columbia
NOW THEREFORE this Agreement witnesses that, in consideration of the premises and the covenants and agreements herein contained, the parties hereto agree as follows:
LICENCE AGREEMENTLicence Agreement • October 24th, 2005 • AnorMED Inc.
ANORMED, INC. a company incorporated in Canada whose principal place of business is #200, 20353 64th Avenue, Langley, B.C. V2Y 1N5, Canada (hereinafter referred to as "AnorMED")
LIMITED DURATION SHAREHOLDER RIGHTS PLAN AGREEMENT dated as of August 29, 2006 BETWEEN ANORMED INC. AND COMPUTERSHARE INVESTOR SERVICES INC. AS RIGHTS AGENTLimited Duration Shareholder Rights Plan Agreement • September 11th, 2006 • AnorMED Inc. • Pharmaceutical preparations • British Columbia
WHEREAS the board of directors of AnorMED has determined that it is in the best interests of AnorMED to adopt a shareholder rights plan to ensure, to the extent possible, that all shareholders of AnorMED are treated fairly in connection with any take-over bid for AnorMED;
AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • October 2nd, 2006 • AnorMED Inc. • Pharmaceutical preparations • Washington
THIS AMENDMENT NO. 1 TO LICENSE AGREEMENT (this “Amendment”), effective as of September 18, 2006 (the “Amendment Date”), is entered into between ANORMED INC. (“AnorMED”), a corporation organized and existing under the laws of Canada and having an office at #200 — 20353 64th Ave, Langley, BC Canada V2Y 1N5, and PONIARD PHARMACEUTICALS, INC. (“Poniard”), a corporation organized and existing under the laws of the State of Washington and having an office at 300 Elliott Avenue West, Suite 500, Seattle, WA 98119, with respect to the following facts:
LICENCE AMENDMENT AGREEMENT Between ANORMED, INC. SHIRE PHARMACEUTICALS GROUP PLC And SHIRE INTERNATIONAL LICENSING B.V. LICENCE AMENDMENT AGREEMENT Relating to the Patent and Know-How Licence for Lanthanum Carbonate and other Compounds dated 9...Agreement • October 24th, 2005 • AnorMED Inc.
SHAREHOLDER SUPPORT AGREEMENTShareholder Support Agreement • October 18th, 2006 • AnorMED Inc. • Pharmaceutical preparations • British Columbia
NOW THEREFORE this Agreement witnesses that, in consideration of the premises and the covenants and agreements herein contained, the parties hereto agree as follows:
